Surabhi Dangi-Garimella, PhD
Articles
Cachexia: A Tool to Identify It Earlier May Improve Survival
November 09, 2016
Article
Recent development of a tool to detect early signs of cachexia, characterized by muscle loss, anorexia and weakness, in patients with cancer may help with early diagnosis, leading to better prognosis and quality of life.
Prioritizing Bone Density Screening Before Embarking on AI Therapy After Breast Cancer
July 28, 2016
Article
A new study has found that as women age, they are actually less like to have baseline bone density testing before embarking on aromatase inhibitor (AI) therapy after breast cancer treatment, even though both increasing age and AI therapy increase fracture risk in postmenopausal women.
Palliative Care Should Begin Early and Engage a Multidisciplinary Team
April 01, 2016
Article
The spotlight was on improving palliative cancer care at the opening session of the 2016 NCCN Annual Meeting, with a panel of experts stressing the importance of delivering these services earlier in the cancer care trajectory and involving teams in the effort.
Young Adults With Cancer Need More Dialogue With Providers on Costs
February 15, 2016
Article
A paper in Cancer Medicine finds that cancer has a devastating and age-specific impact on the finances of young adult survivors, and increased dialogue between healthcare providers and YAs has the potential to empower this population at risk for adverse financial and psychosocial outcomes, and steer them towards reputable sources of financial support.
Study Finds Oral Contraceptive Use Beneficial in Preventing Endometrial Cancer
August 07, 2015
Article
Oral contraceptives may provide long-term protection against endometrial cancer.
USPSTF, ASCO Issue More Guidance on Genetic Testing Based on Family History
April 24, 2014
Article
Oncology practitioners now have several resources to consult for advice on genetic testing for their patients following the US Preventive Services Task Force (USPSTF) December 2013 update of its 2005 BRCA recommendations, plus new recommendations from the American Socieity of Clinical Oncology (ASCO) announced in February and published in the Journal of Clinical Oncology.